Does RUXOLITINIB Cause Terminal state? 73 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 73 reports of Terminal state have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
73
Reports of Terminal state with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
24
Deaths
30
Hospitalizations
How Dangerous Is Terminal state From RUXOLITINIB?
Of the 73 reports, 24 (32.9%) resulted in death, 30 (41.1%) required hospitalization, and 18 (24.7%) were considered life-threatening.
Is Terminal state Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 73 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Terminal state?
LEUPROLIDE (700)
DENOSUMAB (563)
DARBEPOETIN ALFA (299)
CARBIDOPA\LEVODOPA (289)
ADALIMUMAB (253)
OCTREOTIDE (232)
ETANERCEPT (200)
RITUXIMAB (182)
ABATACEPT (181)
CLOZAPINE (180)
Which RUXOLITINIB Alternatives Have Lower Terminal state Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE